BCL26*342337-S39-Biotin 4-Amidobenzoic acid Sodium Salt-Medi

The State of Alabama, through its Office of the Chief Procurement Officer, is soliciting responses for the procurement of Biotin 4-Amidobenzoic acid Sodium Salt (identified as BCL26*342337-S39-Medi) through its Quick Quote procurement process. This is a goods procurement utilizing the Quick Quotes framework, which requires all vendors to register in Alabama Buys and submit responses electronically through that platform. Suppliers must acknowledge receipt of the solicitation and all amendments, confirm understanding of all terms and conditions, and certify non-engagement in collusive bidding practices. The solicitation incorporates by reference the Alabama Department of Finance Administrative Code (Chapters 355-4-1 through 355-4-6, effective October 1, 2022) and establishes Montgomery, Alabama as the sole venue for litigation or dispute resolution. The deadline for proposal submission is April 1, 2026, with the solicitation having been posted on March 25, 2026. Required qualifications include manufacturer authorizations, professional licenses, and insurance certificates as applicable, and suppliers must comply with E-Verify enrollment verification requirements for vendors employing workers in Alabama and provide proof of compliance with Alabama sales tax registration and collection requirements.

The solicitation does not identify specific set-aside designations or restrictions limiting organizational participation to particular disadvantaged enterprise categories within the provided documentation. However, all vendors must complete a Disclosure Statement for contracts exceeding $25,000 and comply with the State's tax exemption status and sales tax certification requirements. The State reserves the right to cancel contracts for justifiable cause with 30 days' notice and retains authority to conduct cost realism and price reasonableness analyses. All vendors must accept multiple forms of electronic payment including state credit cards, P-cards, and EFT transfers at no additional cost. The specific award value or budget range for this procurement is not identified in the available documentation. The State explicitly does not indemnify suppliers or waive its sovereign immunity rights under any circumstances.